Claire Torre

650 total citations
15 papers, 505 citations indexed

About

Claire Torre is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Claire Torre has authored 15 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Hematology and 5 papers in Immunology. Recurrent topics in Claire Torre's work include Immunotherapy and Immune Responses (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Protein Degradation and Inhibitors (5 papers). Claire Torre is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Protein Degradation and Inhibitors (5 papers). Claire Torre collaborates with scholars based in United States. Claire Torre's co-authors include Sagar Lonial, Edmund K. Waller, Jonathan L. Kaufman, Leonard T. Heffner, Dixie‐Lee Esseltine, James R. Berenson, Sundar Jagannath, Bart Barlogie, Kenneth C. Anderson and Seema Singhal and has published in prestigious journals such as Blood, Clinical Cancer Research and Biology of Blood and Marrow Transplantation.

In The Last Decade

Claire Torre

15 papers receiving 490 citations

Peers

Claire Torre

HEMAT

ONCOL

IMMUN

GENET

Catherine Godon France

Mecide Gharibo United States

Raid G. Ossi United States

PR Greipp United States

Rouzbeh Chegeni Canada

Beihui Huang China

Kazutaka Ozeki Japan

Giovanni Marconi Italy

Yu‐Jun Dai China

B Barlogie United States

Catherine Godon France

Claire Torre

307 ×0.9

HEMAT

348 ×1.0

192 ×1.1

ONCOL

40 ×0.7

IMMUN

105 ×2.2

GENET

Citations per year, relative to Claire Torre Claire Torre (= 1×) peers Catherine Godon

Countries citing papers authored by Claire Torre

Since Specialization

Citations

This map shows the geographic impact of Claire Torre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Torre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Torre more than expected).

Fields of papers citing papers by Claire Torre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Torre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Torre. The network helps show where Claire Torre may publish in the future.

Co-authorship network of co-authors of Claire Torre

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Torre. A scholar is included among the top collaborators of Claire Torre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Torre. Claire Torre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Gu, Yanyan, Jonathan L. Kaufman, Claire Torre, et al.. (2014). MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells. Blood. 123(21). 3269–3276. 71 indexed citations

Lonial, Sagar, Mojtaba Akhtari, Jonathan L. Kaufman, et al.. (2012). Mobilization of Hematopoietic Progenitors from Normal Donors Using the Combination of Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor Results in Fewer Plasmacytoid Dendritic Cells in the Graft and Enhanced Donor T Cell Engraftment with Th1 Polarization: Results from a Randomized Clinical Trial. Biology of Blood and Marrow Transplantation. 19(3). 460–467. 13 indexed citations

Lonial, Sagar, Jonathan L. Kaufman, Mourad Tighiouart, et al.. (2010). A Phase I/II Trial Combining High-Dose Melphalan and Autologous Transplant with Bortezomib for Multiple Myeloma: A Dose- and Schedule-Finding Study. Clinical Cancer Research. 16(20). 5079–5086. 69 indexed citations

David, Ebenezer, Jonathan L. Kaufman, Christopher R. Flowers, et al.. (2010). Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes. Blood. 116(24). 5285–5288. 19 indexed citations

Lonial, Sagar, Claire Torre, Ebenezer David, et al.. (2008). Regulation of alloimmune responses by dendritic cell subsets. Experimental Hematology. 36(10). 1309–1317. 11 indexed citations

Lonial, Sagar, Jonathan L. Kaufman, Claire Torre, et al.. (2008). A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.. Blood. 112(11). 3332–3332. 4 indexed citations

Lonial, Sagar, Jonathan L. Kaufman, Amelia Langston, et al.. (2007). A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.. Blood. 110(11). 949–949. 3 indexed citations

Torre, Claire, Ebenezer David, Leif Bergsagel, et al.. (2007). A Novel Pan-PI3K/Akt Inhibitor, SF1126, Inhibits In Vitro Growth of Multiple Myeloma Cells.. Blood. 110(11). 4806–4806. 3 indexed citations

Lonial, Sagar, Claire Torre, Amelia Langston, et al.. (2006). A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.. Blood. 108(11). 3377–3377. 2 indexed citations

10.

Lonial, Sagar, Claire Torre, Amelia Langston, et al.. (2005). A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.. Blood. 106(11). 1960–1960. 2 indexed citations

11.

Lonial, Sagar, Edmund K. Waller, Paul G. Richardson, et al.. (2005). Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma. Blood. 106(12). 3777–3784. 263 indexed citations

12.

Kaufman, Jonathan L., et al.. (2005). Enhanced Levels of Apoptosis by Combination of Farnesyl Transferase Inhibition (Tipifarnib) and Proteasome Inhibition (Bortezomib) in Myeloma Cell Lines and Primary Myeloma Cells and Its Mechanistic Effects on Akt and Caspase Pathways.. Blood. 106(11). 1573–1573. 5 indexed citations

13.

Sinha, Rajni, et al.. (2005). Combination of Akt/PKB Inhibition (Perifosine) and Farnesyl Transferase Inhibition (Tipifarnib) Results in Increased Cell Death in Myeloma Cells Lines.. Blood. 106(11). 1568–1568. 4 indexed citations

14.

David, Ebenezer, et al.. (2005). Combination of Farnesyl Transferase Inhibitor (Tipifarnib) with Perifosine Induces Apoptosis through phos-PDK1 in Human Lymphoma and Leukemia Cell Lines.. Blood. 106(11). 1488–1488. 3 indexed citations

15.

Lonial, Sagar, Hilary Rosenthal, Amelia Langston, et al.. (2004). A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Biology of Blood and Marrow Transplantation. 10(12). 848–857. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact